Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Osivax
Sort By
Newest First
1 / 1
1 / 1
Osivax Receives Over EUR 30M in Public Funding to Support Development of Universal Coronavirus and Influenza Vaccines
Osivax
PR-M07-20-NI-010
Jul 09, 2020
